Beta Bionics targets $695 mln valuation in upsized US IPO

Beta Bionics targets $695 mln valuation in upsized US IPO

Source: 
Medtech Dive
snippet: 

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 million in the fourth quarter.